Welcoming Dr. Asim Mian and Dr. Ling Lam to Our Advisory Board
April 1, 2024
RhoScan AI is proud to announce the addition of two distinguished neuroradiologists, Dr. Asim Mian and Dr. Ling Lam, to our advisory board. Their extensive experience and expertise in the field of radiology will be invaluable as we continue to develop and refine our AI-powered medical imaging solutions.
Dr. Asim Mian
Dr. Asim Mian is an Assistant Professor of Radiology in Neuroradiology at the Chobanian and Avedisian School of Medicine. With a distinguished career spanning over two decades, Dr. Mian brings a wealth of experience and innovation to our advisory board.
Key highlights of Dr. Mian's career include:
- Creator of the functional MRI (fMRI) program at Boston Medical Center
- Extensive experience in treating stroke and trauma victims
- Research interests in Alzheimer's, white matter diseases, and brain tumor imaging
- Co-investigator in multiple NIH-funded studies
Dr. Mian's expertise in advanced neuroimaging techniques and his research focus on critical areas such as Alzheimer's and brain tumors align perfectly with RhoScan AI's mission to enhance diagnostic accuracy and improve patient outcomes through AI-powered medical imaging.
Dr. Ling Lam
Dr. Ling Lam is a highly experienced neuroradiologist based in East Brunswick, NJ, with over 31 years of experience in the medical field. Her extensive background and expertise make her a valuable addition to our advisory board.
Key aspects of Dr. Lam's distinguished career include:
- Board Certification from the American Board of Radiology (1998) in Diagnostic Radiology
- Certificate of Added Qualifications in Neuroradiology (2001)
- Extensive experience across multiple prestigious medical institutions
- Specialized training in neuroradiology from New York University Medical Center
Dr. Lam's wealth of clinical experience and her specialization in neuroradiology will provide crucial insights as we develop AI solutions tailored to the complex needs of neurological imaging.
Impact on RhoScan AI's Future
The addition of Dr. Mian and Dr. Lam to our advisory board marks a significant step forward for RhoScan AI. Their combined expertise will be instrumental in guiding our research and development efforts, ensuring that our AI solutions meet the highest standards of clinical relevance and efficacy.
Our CEO, Olaitan Olaitan, commented on these appointments: "We are thrilled to welcome Dr. Mian and Dr. Lam to our advisory board. Their extensive experience in neuroradiology and their commitment to advancing medical imaging will be invaluable as we continue to develop our AI-powered solutions. Their insights will help ensure that our technology not only pushes the boundaries of what's possible in AI but also addresses the real-world needs of radiologists and patients."
The addition of these esteemed professionals to our advisory board underscores RhoScan AI's commitment to combining cutting-edge AI technology with deep clinical expertise. As we continue to innovate in the field of AI-powered medical imaging, the guidance of Dr. Mian and Dr. Lam will be crucial in ensuring that our solutions deliver meaningful improvements in patient care and clinical outcomes.
We look forward to the contributions of Dr. Mian and Dr. Lam and are excited about the future developments their expertise will help shape at RhoScan AI.
Stay tuned for more updates on how these new advisory board members will influence our product development and research initiatives.